Johnson & Johnson
Get $10 bonus on your first $100 deposit for JNJ.DE
Get $10 bonus on your first $100 deposit for JNJ.DE
Johnson & Johnson (JNJ.DE) Stock Competitors & Peer Comparison
See (JNJ.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| JNJ.DE | €201.50 | -0.07% | 491.6B | 21.58 | €9.46 | +2.18% |
| LLY.DE | €772.20 | -2.99% | 749.1B | 40.31 | €19.67 | +0.68% |
| 4AB.DE | €175.40 | +0.72% | 312.5B | 87.45 | €2.02 | +3.24% |
| 6MK.DE | €99.45 | -2.58% | 251.9B | 16.33 | €6.24 | +2.79% |
| ZEG.DE | €160.70 | +0.59% | 249.2B | 28.75 | €5.59 | +1.69% |
| AMG.DE | €293.20 | -1.23% | 160.1B | 24.31 | €12.22 | +2.78% |
| GIS.DE | €117.60 | +0.29% | 147.8B | 20.53 | €5.80 | +2.30% |
| PFE.F | €23.12 | +0.57% | 131.5B | 19.93 | €1.16 | +6.36% |
| PFE.DE | €22.96 | +0.15% | 131.5B | 19.93 | €1.16 | +6.35% |
| BRM.DE | €48.86 | -1.11% | 101B | 16.76 | €2.96 | +4.32% |
Stock Comparison
JNJ.DE vs LLY.DE Comparison April 2026
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 491.6B. In comparison, LLY.DE has a market cap of 749.1B. Regarding current trading prices, JNJ.DE is priced at €201.50, while LLY.DE trades at €772.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 21.58, whereas LLY.DE's P/E ratio is 40.31. In terms of profitability, JNJ.DE's ROE is +0.34%, compared to LLY.DE's ROE of +0.98%. Regarding short-term risk, JNJ.DE is less volatile compared to LLY.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.Check LLY.DE's competition here
JNJ.DE vs 4AB.DE Comparison April 2026
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 491.6B. In comparison, 4AB.DE has a market cap of 312.5B. Regarding current trading prices, JNJ.DE is priced at €201.50, while 4AB.DE trades at €175.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 21.58, whereas 4AB.DE's P/E ratio is 87.45. In terms of profitability, JNJ.DE's ROE is +0.34%, compared to 4AB.DE's ROE of -3.62%. Regarding short-term risk, JNJ.DE is less volatile compared to 4AB.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.Check 4AB.DE's competition here
JNJ.DE vs 6MK.DE Comparison April 2026
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 491.6B. In comparison, 6MK.DE has a market cap of 251.9B. Regarding current trading prices, JNJ.DE is priced at €201.50, while 6MK.DE trades at €99.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 21.58, whereas 6MK.DE's P/E ratio is 16.33. In terms of profitability, JNJ.DE's ROE is +0.34%, compared to 6MK.DE's ROE of +0.36%. Regarding short-term risk, JNJ.DE is less volatile compared to 6MK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.Check 6MK.DE's competition here
JNJ.DE vs ZEG.DE Comparison April 2026
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 491.6B. In comparison, ZEG.DE has a market cap of 249.2B. Regarding current trading prices, JNJ.DE is priced at €201.50, while ZEG.DE trades at €160.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 21.58, whereas ZEG.DE's P/E ratio is 28.75. In terms of profitability, JNJ.DE's ROE is +0.34%, compared to ZEG.DE's ROE of +0.23%. Regarding short-term risk, JNJ.DE is less volatile compared to ZEG.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.Check ZEG.DE's competition here
JNJ.DE vs AMG.DE Comparison April 2026
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 491.6B. In comparison, AMG.DE has a market cap of 160.1B. Regarding current trading prices, JNJ.DE is priced at €201.50, while AMG.DE trades at €293.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 21.58, whereas AMG.DE's P/E ratio is 24.31. In terms of profitability, JNJ.DE's ROE is +0.34%, compared to AMG.DE's ROE of +0.97%. Regarding short-term risk, JNJ.DE is less volatile compared to AMG.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.Check AMG.DE's competition here
JNJ.DE vs GIS.DE Comparison April 2026
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 491.6B. In comparison, GIS.DE has a market cap of 147.8B. Regarding current trading prices, JNJ.DE is priced at €201.50, while GIS.DE trades at €117.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 21.58, whereas GIS.DE's P/E ratio is 20.53. In terms of profitability, JNJ.DE's ROE is +0.34%, compared to GIS.DE's ROE of +0.41%. Regarding short-term risk, JNJ.DE is less volatile compared to GIS.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.Check GIS.DE's competition here
JNJ.DE vs PFE.F Comparison April 2026
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 491.6B. In comparison, PFE.F has a market cap of 131.5B. Regarding current trading prices, JNJ.DE is priced at €201.50, while PFE.F trades at €23.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 21.58, whereas PFE.F's P/E ratio is 19.93. In terms of profitability, JNJ.DE's ROE is +0.34%, compared to PFE.F's ROE of +0.09%. Regarding short-term risk, JNJ.DE is more volatile compared to PFE.F. This indicates potentially higher risk in terms of short-term price fluctuations for JNJ.DE.Check PFE.F's competition here
JNJ.DE vs PFE.DE Comparison April 2026
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 491.6B. In comparison, PFE.DE has a market cap of 131.5B. Regarding current trading prices, JNJ.DE is priced at €201.50, while PFE.DE trades at €22.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 21.58, whereas PFE.DE's P/E ratio is 19.93. In terms of profitability, JNJ.DE's ROE is +0.34%, compared to PFE.DE's ROE of +0.09%. Regarding short-term risk, JNJ.DE is more volatile compared to PFE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for JNJ.DE.Check PFE.DE's competition here
JNJ.DE vs BRM.DE Comparison April 2026
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 491.6B. In comparison, BRM.DE has a market cap of 101B. Regarding current trading prices, JNJ.DE is priced at €201.50, while BRM.DE trades at €48.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 21.58, whereas BRM.DE's P/E ratio is 16.76. In terms of profitability, JNJ.DE's ROE is +0.34%, compared to BRM.DE's ROE of +0.39%. Regarding short-term risk, JNJ.DE is less volatile compared to BRM.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.Check BRM.DE's competition here
JNJ.DE vs SNW.DE Comparison April 2026
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 491.6B. In comparison, SNW.DE has a market cap of 97.5B. Regarding current trading prices, JNJ.DE is priced at €201.50, while SNW.DE trades at €81.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 21.58, whereas SNW.DE's P/E ratio is 20.11. In terms of profitability, JNJ.DE's ROE is +0.34%, compared to SNW.DE's ROE of +0.15%. Regarding short-term risk, JNJ.DE is more volatile compared to SNW.DE. This indicates potentially higher risk in terms of short-term price fluctuations for JNJ.DE.Check SNW.DE's competition here
JNJ.DE vs BAYN.SG Comparison April 2026
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 491.6B. In comparison, BAYN.SG has a market cap of 40B. Regarding current trading prices, JNJ.DE is priced at €201.50, while BAYN.SG trades at €40.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 21.58, whereas BAYN.SG's P/E ratio is N/A. In terms of profitability, JNJ.DE's ROE is +0.34%, compared to BAYN.SG's ROE of -0.12%. Regarding short-term risk, JNJ.DE is less volatile compared to BAYN.SG. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.Check BAYN.SG's competition here
JNJ.DE vs BAYN.DE Comparison April 2026
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 491.6B. In comparison, BAYN.DE has a market cap of 39.9B. Regarding current trading prices, JNJ.DE is priced at €201.50, while BAYN.DE trades at €40.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 21.58, whereas BAYN.DE's P/E ratio is -11.04. In terms of profitability, JNJ.DE's ROE is +0.34%, compared to BAYN.DE's ROE of -0.12%. Regarding short-term risk, JNJ.DE is less volatile compared to BAYN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.Check BAYN.DE's competition here
JNJ.DE vs IDP.DE Comparison April 2026
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 491.6B. In comparison, IDP.DE has a market cap of 22.5B. Regarding current trading prices, JNJ.DE is priced at €201.50, while IDP.DE trades at €151.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 21.58, whereas IDP.DE's P/E ratio is 20.40. In terms of profitability, JNJ.DE's ROE is +0.34%, compared to IDP.DE's ROE of +0.07%. Regarding short-term risk, JNJ.DE is more volatile compared to IDP.DE. This indicates potentially higher risk in terms of short-term price fluctuations for JNJ.DE.Check IDP.DE's competition here
JNJ.DE vs GS7.DE Comparison April 2026
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 491.6B. In comparison, GS7.DE has a market cap of 0. Regarding current trading prices, JNJ.DE is priced at €201.50, while GS7.DE trades at €20.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 21.58, whereas GS7.DE's P/E ratio is 17.31. In terms of profitability, JNJ.DE's ROE is +0.34%, compared to GS7.DE's ROE of +0.34%. Regarding short-term risk, JNJ.DE is less volatile compared to GS7.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.Check GS7.DE's competition here